1Maedler K, Spinas GA, Lehmann R, et al.Glucose induces β-cell apotosis via upregulation of the fas receptor in human islets. Diabetes,2001,50:1683-1690.
2Antonio C. New insights on oxidant stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care,2003,26: 1589-1596
3Virag L, Salzman AL, Szabo C. Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol, 1998,161: 3753-3759.
4Felix C, Gillis M, Driedzic WR, et al. Effects of propionyl-L-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart. Diabetes Res Clin Pract,2001,53: 17-21.
5Coppey LJ, Gellett JS, Davidson EP, et al. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes, 2001,50: 1927-1937.
6Kowluru RA. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated. Acta Diabetol, 2001,38: 179-185.
7Garcia SF, Virag L, Jagatap P, et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med, 2001,7: 108-113.
8Szabo C, Mabley JG, Moeller SM, et al. Pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med, 2002,8: 571-580.
9Shiojiri T, Wada K, Nakajima A, et al. PPAR-gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice. Eur J Pharmacol, 2002,448: 231-238.
10Masao T, Koichi N, Hironori N, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.J Clin Invest, 2001, 108: 1429-1437.
